| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1449.5% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 83.1 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (21.18) | (45.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (28.73) | (55.84)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (30.94) | (51.54)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (25.92) | (31.14)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 1.31 | (27.25) | (25.77)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Suspension - Faron Pharmaceuticals Oy | 30-Mar-2026 | 07:30 | RNS |
| FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY | 12-Mar-2026 | 14:30 | RNS |
| The Finnish Financial Supervisory Authority has ... | 11-Mar-2026 | 18:20 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 41.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 246.97 |
| 52 Week Low | 39.00 |
| Volume | 41,536 |
| Shares Issued | 224.35m |
| Market Cap | £91.98m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:25 | 2,000 @ 41.80p |
| 16:13 | 500 @ 40.21p |
| 16:05 | 500 @ 40.21p |
| 14:30 | 4,337 @ 41.50p |
| 14:00 | 2,500 @ 41.00p |
| CEO | Juho Jalkanen |
| Chair | Tuomo Pätsi |
| CFO | Jurriaan Dekkers |
You are here: research